In addition to the known DEGs, this study, for the first time, reported a set of new diagnostic biomarkers in HCC patients, such as CDC14B, CCNE1, CCNE2, and CDKN2C. This evidence concerns the gene CCNE1 and hepatocellular carcinoma.